CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 685 enrolled
Drug / intervention
Genecept Assaydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01507155
NCT01507155N/ACompleted
CompareCT.gov

An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay

Genomind, LLC·interventional·Posted Jan 10, 2012·Updated Jun 8, 2016

In Brief

A clinical study evaluating Genecept Assay for Treatment Resistant Depression and Generalized Anxiety Disorder. Completed, enrolled 685 participants across 1 site.

Detailed Summary

Genomind has developed and introduced a battery of genetic tests, the Genecept Assay, which clinicians can administer to patients using a simple saliva sample technique. The present study proposes to enroll 1. Subjects (patients who have consented to using the Genecept Assay) and 2. Clinician study participants (clinicians who have ordered the Assay on behalf of their patients). This study will involve the collection of responses from both Subjects and clinician study participants with the intention of correlating this information to Subject genetic data.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTreatment Resistant Depression, Generalized Anxiety Disorder
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 10, 2012
Enrollment StartApr 1, 2013
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 14.5 years ago

Interventions

Genecept Assaydevice

Genetic test which analyzes seven pharmacodynamic and three pharmacokinetic genes important in psychiatric disorders